For patients with Crohn's disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy is showing results that offer hope for one of medicine's most treatment-resistant populations, ...
2 hours ago
0
1
A swarm of tiny, shape-changing, all-metal robots might someday deliver drugs and capture biopsy samples painlessly and then safely dissolve without the need for extraction, according to a study presented at Digestive Disease ...
2 hours ago
0
1
Although the United States requires a warning label on alcoholic beverages, alcohol-related deaths have risen steadily over the past two decades. However, new labels warning of specific disease risks, including cancer and ...
2 hours ago
0
0
Multiple sclerosis (MS) is most prevalent in Northern Europe and Canada, and more common in the northernmost latitudes. In recent years, the number of cases has grown, particularly among women. The disease causes the patient's ...
11 hours ago
0
10
Omega-3 supplements are popular among many older adults to help combat age-related issues. They are often marketed as supporting cardiovascular health and reducing the risk of cognitive decline and dementia. However, a new ...
Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults. Professor ...
12 hours ago
0
8
Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs ...
11 hours ago
0
5
We don't usually realize it, but every word we speak depends on a series of complex brain processes working behind the scenes. One important part of this is speech motor learning, the brain's ability to learn and remember ...
Researchers at the University of Cincinnati Gardner Neuroscience Institute's Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy ...
12 hours ago
0
7
Scientists from A*STAR Infectious Diseases Labs (A*STAR IDL), Nanyang Technological University, Singapore's Lee Kong Chian School of Medicine (LKCMedicine), the National University of Singapore (NUS), and international collaborators ...
12 hours ago
0
4
